Related Experiment Videos
Hypercholesterolemia after chemotherapy for testis cancer
1Department of Nursing, Royal Prince Alfred Hospital, Camperdown, Australia.
Summary
Cisplatin chemotherapy for germ cell tumors can increase serum cholesterol levels. This study confirms cholesterol increases in patients undergoing this cancer treatment, highlighting potential long-term effects.
Area of Science:
- Oncology
- Cardiovascular Medicine
- Pharmacology
Background:
- Germ cell tumors are a significant concern in oncology.
- Cisplatin-based chemotherapy is a standard treatment for germ cell tumors.
- Previous observations suggested potential lipid abnormalities following chemotherapy.
Purpose of the Study:
- To prospectively determine the prevalence of fasting serum lipid abnormalities in patients treated with cisplatin-based chemotherapy for germ cell tumors.
- To further investigate the phenomenon of hypercholesterolemia observed in prior studies.
- To assess the impact of cisplatin chemotherapy on lipid profiles.
Main Methods:
- Seventeen patients with germ cell tumors undergoing cisplatin chemotherapy were studied.
- Fasting lipid screens (cholesterol, triglycerides, HDL, apolipoproteins) were performed before, during, and after treatment.
- Patients had no prior history of cardiac disease or hypercholesterolemia.
Main Results:
- 41% of patients (7 of 17) exhibited undesirable levels of total and LDL cholesterol.
- 14 of 17 patients showed absolute increases in serum cholesterol.
- No consistent changes were observed in other serum lipids.
Conclusions:
- Serum cholesterol increases were confirmed in patients receiving cisplatin-containing chemotherapy for germ cell tumors.
- Further research is needed to identify other potential lipid abnormalities.
- The biological significance of these cisplatin-induced lipid changes requires further investigation.